← All trials
NCT05203965
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 17, 2022
- Primary completion
- Jul 31, 2023
- Completion date
- Apr 30, 2024
- First posted
- Jan 24, 2022
- Last posted
- Jun 3, 2022
- Enrollment
- 80
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Yale UniversityLead sponsor
- Yale UniversityOverall official - principal investigator
- Yale UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.